Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence
Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence
MAULDIN, SC / ACCESSWIRE / March 25, 2024 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it has retained Darrow Associates to represent the Company as its investor relations ("IR") advisor. In this capacity, Darrow Associates will support Xcelerate as the primary contact with investors and seek to increase awareness of the Company's growth opportunities with the broader financial community.
南卡羅來納州莫爾丁/ACCESSWIRE/2024年3月25日/Xcelerate, Inc.（OTCQB: XCRT）今天宣佈，它已聘請Darrow Associates代表公司擔任其投資者關係（“IR”）顧問。Darrow Associates將以此身份支持Xcelerate作爲與投資者的主要聯繫人，並努力提高更廣泛的金融界對公司增長機會的認識。
"We are excited about the new partnership with Darrow Associates as our IR representative," said Mike O'Shea, CEO of Xcelerate. "We have much work ahead of us to enhance our investor communication strategy and effectively relay our exciting story to the investment community. The Darrow Associates team has significant and highly relevant IR experience as well as an outstanding investment community network, which we believe will complement the leadership of Xcelerate as we work together to communicate our value to investors."
Xcelerate首席執行官邁克·奧謝說：“我們對與作爲投資者關係代表的Darrow Associates建立新的合作伙伴關係感到興奮。”“要加強我們的投資者溝通策略並有效地向投資界傳達我們的激動人心的故事，我們還有很多工作要做。Darrow Associates團隊擁有豐富且高度相關的投資者關係經驗以及出色的投資社區網絡，我們相信這將補充Xcelerate的領導地位，共同努力向投資者傳達我們的價值。”
About Xcelerate, Inc.
關於 Xcelerate, Inc.
Xcelerate is a healthcare services and products company engaged in three separate but related businesses within the medical, health and wellness sectors; 1) Development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through our technology; 2) Formulating, packaging and marketing of clinically tested health and beauty; 3) Owing and or licensing of rights and patents to various forms of medical equipment.
Xcelerate是一家醫療保健服務和產品公司，在醫療、健康和保健領域從事三項獨立但相關的業務；1）開發醫療技術和虛擬健康服務，通過我們的技術擴大醫生的覆蓋範圍，幫助發展中國家的患者滿足其醫療需求；2）制定、包裝和營銷經過臨床測試的健康和美容產品；3）擁有和/或許可各種形式的醫療設備的權利和專利。
About Darrow Associates
關於達羅協會
Darrow Associates is an investor relations and financial communications firm with coverage throughout the United States. The firm was established in New York in 2005 and since that time has added to its professional staff to become one of the largest and most trusted IR consulting firms for middle market companies. Darrow Associates professionals have significant experience in partnering with public and pre-IPO companies in the technology, media and telecommunications (TMT), business services, alternative energy, clean technology, healthcare/medtech, financial services, industrial, and aerospace and defense industries. Additional information is available at .
Darrow Associates是一家投資者關係和金融傳播公司，業務覆蓋美國各地。該公司於2005年在紐約成立，此後增加了專業人員，成爲中間市場公司規模最大、最值得信賴的投資者關係諮詢公司之一。Darrow Associates的專業人員在與科技、媒體和電信（TMT）、商業服務、替代能源、清潔技術、醫療保健/醫療技術、金融服務、工業以及航空航天和國防行業的上市公司和上市前公司合作方面擁有豐富的經驗。其他信息可在以下網址獲得。
SAFE HARBOR
安全港
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.
本新聞稿可能包含經修訂的1934年《證券交易法》（“交易法”）第21E條所指的前瞻性信息，包括所有非歷史事實陳述的陳述，這些陳述涉及公司、其董事或高級管理人員在以下方面的意圖、信念或當前期望：（i）公司的融資計劃；（ii）影響公司財務狀況或經營業績的趨勢；（iii）公司的增長戰略和運營戰略；以及 (iv)股息的申報和支付。“可能”、“會”、“將”、“期望”、“估計”、“預期”、“相信”、“打算” 等詞以及類似的表述和變體旨在識別前瞻性陳述。投資者請注意，任何此類前瞻性陳述都不能保證未來的表現，並涉及風險和不確定性，其中許多風險和不確定性超出了公司的控制能力，實際業績可能與前瞻性陳述中的預測存在重大差異 由於 各種因素。
Contacts
聯繫人
Investors:
Matt Kreps
214-597-8200
mkreps@darrowir.com
投資者：
馬特·克雷普斯
214-597-8200
mkreps@darrowir.com
SOURCE: Xcelerate, Inc.
資料來源：Xcelerate, Inc.
譯文內容由第三人軟體翻譯。